Advisornet Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.21M | Sell |
38,342
-322
| -0.8% | -$18.5K | 0.1% | 172 |
|
|
2026
Q1 | $2.34M | Sell |
38,664
-754
| -2% | -$44K | 0.12% | 153 |
|
|
2025
Q4 | $2.13M | Buy |
39,418
+2,575
| +7% | +$124K | 0.11% | 155 |
|
|
2025
Q3 | $1.66M | Sell |
36,843
-471
| -1% | -$22K | 0.09% | 188 |
|
|
2025
Q2 | $1.73M | Buy |
37,314
+2,028
| +6% | +$99.6K | 0.11% | 181 |
|
|
2025
Q1 | $2.15M | Buy |
35,286
+479
| +1% | +$27.9K | 0.16% | 148 |
|
|
2024
Q4 | $1.97M | Sell |
34,807
-1,415
| -4% | -$79.1K | 0.16% | 136 |
|
|
2024
Q3 | $1.87M | Buy |
36,222
+770
| +2% | +$36.1K | 0.14% | 157 |
|
|
2024
Q2 | $1.47M | Buy |
35,452
+2,073
| +6% | +$92.8K | 0.13% | 159 |
|
|
2024
Q1 | $1.81M | Buy |
33,379
+4,138
| +14% | +$211K | 0.17% | 136 |
|
|
2023
Q4 | $1.5M | Sell |
29,241
-1,480
| -5% | -$77.7K | 0.14% | 171 |
|
|
2023
Q3 | $1.78M | Sell |
30,721
-13,124
| -30% | -$804K | 0.16% | 134 |
|
|
2023
Q2 | $2.8M | Buy |
43,845
+1,760
| +4% | +$118K | 0.24% | 101 |
|
|
2023
Q1 | $2.92M | Buy |
42,085
+180
| +0.4% | +$12.7K | 0.27% | 92 |
|
|
2022
Q4 | $3.02M | Sell |
41,905
-198
| -0.5% | -$14.9K | 0.3% | 82 |
|
|
2022
Q3 | $2.99M | Buy |
42,103
+2,430
| +6% | +$176K | 0.3% | 85 |
|
|
2022
Q2 | $3.06M | Buy |
39,673
+7,211
| +22% | +$549K | 0.3% | 89 |
|
|
2022
Q1 | $2.37M | Buy |
32,462
+924
| +3% | +$62K | 0.15% | 140 |
|
|
2021
Q4 | $1.97M | Sell |
31,538
-296
| -0.9% | -$17.4K | 0.12% | 159 |
|
|
2021
Q3 | $1.88M | Sell |
31,834
-37,318
| -54% | -$2.46M | 0.13% | 149 |
|
|
2021
Q2 | $4.62M | Buy |
69,152
+1,466
| +2% | +$95.6K | 0.31% | 76 |
|
|
2021
Q1 | $4.27M | Buy |
67,686
+2,542
| +4% | +$158K | 0.3% | 75 |
|
|
2020
Q4 | $4.04M | Buy |
65,144
+551
| +0.9% | +$33.9K | 0.33% | 63 |
|
|
2020
Q3 | $3.89M | Buy |
64,593
+1,539
| +2% | +$92.6K | 0.33% | 61 |
|
|
2020
Q2 | $3.71M | Sell |
63,054
-2,888
| -4% | -$173K | 0.3% | 74 |
|
|
2020
Q1 | $3.68M | Sell |
65,942
-3,848
| -6% | -$235K | 0.34% | 67 |
|
|
2019
Q4 | $4.48M | Buy |
69,790
+1,492
| +2% | +$85.4K | 0.38% | 56 |
|
|
2019
Q3 | $3.46M | Buy |
68,298
+277
| +0.4% | +$13K | 0.32% | 69 |
|
|
2019
Q2 | $3.08M | Buy |
68,021
+35,441
| +109% | +$1.65M | 0.34% | 66 |
|
|
2019
Q1 | $1.55M | Sell |
32,580
-126
| -0.4% | -$6.28K | 0.19% | 119 |
|
|
2018
Q4 | $1.7M | Sell |
32,706
-320
| -1% | -$17.2K | 0.23% | 96 |
|
|
2018
Q3 | $2.05M | Buy |
33,026
+728
| +2% | +$43.2K | 0.26% | 84 |
|
|
2018
Q2 | $1.79M | Buy |
32,298
+642
| +2% | +$34.7K | 0.24% | 86 |
|
|
2018
Q1 | $2M | Buy |
31,656
+661
| +2% | +$42.5K | 0.28% | 74 |
|
|
2017
Q4 | $1.9M | Buy |
+30,995
| New | +$1.94M | 0.29% | 72 |
|
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Advisornet Financial's BMY Position: Q2 2026 in Review
Advisornet Financial reduced its Bristol-Myers Squibb (BMY) stake by 0.83% in Q2 2026, selling an estimated $18.5K and leaving 38,342 shares worth $2.21M. The position accounts for 0.1% of the portfolio, ranked #172.
Advisornet Financial first reported a position in BMY in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.62M in Q2 2021. 778 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Advisornet Financial held 38,342 shares of Bristol-Myers Squibb worth $2.21M as of Q2 2026.
- Advisornet Financial sold 322 Bristol-Myers Squibb shares in Q2 2026, an estimated $18.5K.
- Bristol-Myers Squibb made up 0.1% of Advisornet Financial's portfolio in Q2 2026, its #172 holding.
- Advisornet Financial first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Bristol-Myers Squibb position peaked at $4.62M in Q2 2021.
- 778 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.